Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

CORESTATE Capital logo
€0.29 -0.03 (-8.75%)
As of 04/17/2025

About CORESTATE Capital Stock (ETR:CCAP)

Key Stats

Today's Range
€0.29
€0.34
50-Day Range
€0.24
€0.40
52-Week Range
€0.26
€0.76
Volume
919 shs
Average Volume
N/A
Market Capitalization
$48.42 million
P/E Ratio
N/A
Dividend Yield
856.16%
Price Target
N/A
Consensus Rating
N/A

Company Overview

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CCAP Stock News Headlines

Corestate Capital Holding SA
Is it CRAZY to still want reliable profits, despite this market?
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who – while everyone else watched their retirement get cut in half in 2008... Performed 103% better than the market. And the one who crushed the market by 4X during the COVID meltdown.
Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
KBW Releases a Buy Rating on Crescent Capital BDC (CCAP)
See More Headlines

CCAP Stock Analysis - Frequently Asked Questions

CORESTATE Capital's stock was trading at €0.36 at the start of the year. Since then, CCAP shares have decreased by 18.9% and is now trading at €0.29.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Aravive (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Real Estate Services
Sub-Industry
Financial Services
Current Symbol
ETR:CCAP
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.01
Net Income
$-3,499,186,007.47
Net Margins
-1,143.36%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$306.04 million
Cash Flow
€0.49 per share
Price / Cash Flow
0.60
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$48.42 million
Optionable
Not Optionable
Beta
1.03
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ETR:CCAP) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners